{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"1.750","rs_stock_flag":false,"fiscal_year_end":"","hist_closedate":"","replication_method":null,"amt_os":"","primaryexch":"香港交易所","ric":"2953.HK","product_subtype":"RGHT","db_updatetime":"2025年10月16日09:36","mkt_cap_u":"","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BRBWT51","am":"2.47","iv":"","ew_strike":"","as":"1.170","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"1.090","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"1,000","update_time":"2025-10-16 01:36:30.0","lo52":"","shares_issued_date":"","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":null,"underlying_ric":"6978.HK","hi52":"","issuer_name":"永泰生物製藥有限公司 - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年10月16日10:17","aum_date":"","lo":"1.090","mkt_cap":"","f_aum_hkd":null,"ew_sub_per_to":"","ls":"1.090","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"0","aum":"","issued_shares_class_B":null,"vo":"2.09","secondary_listing_flag":false,"listing_date":"2025年10月16日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"永泰生物製藥有限公司 - B - 股權證","nm_s":"永泰生物－Ｂ股權","sym":"2953","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"永泰生物製藥有限公司是一家主要從事用於治療癌症的細胞免疫產品的研發、製造及商業化的投資控股公司。該公司的非轉基因細胞產品管線包括EAL和6B11-OCIK注射液。該公司的嵌合抗原受體T（CAR-T）細胞產品管線包括CAR-T-19注射液、迪諾侖賽注射液和aT19注射液。該公司的T細胞受體工程化T細胞療法（TCR-T）細胞產品管線包括YT003、YT008及YT007。該公司主要在國內市場開展業務。","op":"1.750","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港銅鑼灣<br/>勿地臣街1號<br/>時代廣場<br/>二座31樓","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"","isin":"KYG4721A1186","moneyness":""}},"qid":"1760581984578"}
